Global Apomorphine Hydrochloride Market Growth 2023-2029

Global Apomorphine Hydrochloride Market Growth 2023-2029

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
LPI (LP Information)' newest research report, the “Apomorphine Hydrochloride Industry Forecast” looks at past sales and reviews total world Apomorphine Hydrochloride sales in 2022, providing a comprehensive analysis by region and market sector of projected Apomorphine Hydrochloride sales for 2023 through 2029. With Apomorphine Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Apomorphine Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Apomorphine Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Apomorphine Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Apomorphine Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Apomorphine Hydrochloride and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Apomorphine Hydrochloride.
The global Apomorphine Hydrochloride market size is projected to grow from US$ 271.7 million in 2022 to US$ 358.6 million in 2029; it is expected to grow at a CAGR of 358.6 from 2023 to 2029.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report presents a comprehensive overview, market shares, and growth opportunities of Apomorphine Hydrochloride market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Segmentation by application
Parkinson Disease
Erectile Dysfunction
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion

Key Questions Addressed in this Report
What is the 10-year outlook for the global Apomorphine Hydrochloride market?
What factors are driving Apomorphine Hydrochloride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Apomorphine Hydrochloride market opportunities vary by end market size?
How does Apomorphine Hydrochloride break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.